Research & Development

1.Oncology Enterprise

We prioritize the allocation of research and development resources to the field of oncology, an area in which global issues regarding access to healthcare are faced in both developed and developing countries.

Daiichi Sankyo Cancer Enterprise

2.Combating rare diseases

We tackle rare diseases and preventive medicine which are the global issues.

Continued initiatives targeting rare diseases

3.Partnership initiatives

In order to make effective use of our resources, we will advance research and development ventures with an aim to engaging in partnerships with various public- and private-sector entities.

Partnership initiatives

TaNeDS

4.Open Innovation

We have been focusing on open innovation activities and have taken many approaches for expansion of external networks for creating new drugs and securement of various innovation sources, such as collaborative research, sharing compound library and funding.

Open Innovation

5.Scholarships for Contributing to the Advancement of Medicine and Pharmacology

We provide scholarships aimed at supporting research for contributing to the advancement of medicine and pharmacology in accordance with strict procedures.

Scholarships for medicine and pharmacy

6.Disclosure of Clinical Trials

We recognize that it is important to properly disclose clinical trials as a sponsor to a wide range of stakeholders in accordance with regulations and guidelines of each country/industry associations. Accordingly, we practice proactive information disclosure. Furthermore, it is also important to share clinical trial data to outside researchers to deepen their understanding of medicines, to disseminate scientific knowledge, which will lead the development of medical care for patients.

Clinical Trial Information Disclosure